Skip to content
10-K

Annual Report

ONCOVISTA INNOVATIVE THERAPIES, INC

0001144204-12-018616

← back to feed
Filed
Mar 30, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Mar 26, 2012 21.37M sh
Capex FY 2011 · Dec 31, 2011 $2.86K
Capex FY 2011 · Dec 31, 2010 $0
Operating Cash Flow FY 2011 · Dec 31, 2010 −$554.95K
Current Liabilities FY 2011 · Dec 31, 2010 $1.89M
Current Assets FY 2011 · Dec 31, 2010 $3.53M
Total Assets FY 2011 · Dec 31, 2010 $3.55M
Sga Expense FY 2011 · Dec 31, 2010 $1.95M
Rd Expense FY 2011 · Dec 31, 2010 $450.91K
Net Income FY 2011 · Dec 31, 2010 $10.1M
Operating Income FY 2011 · Dec 31, 2010 −$2.4M
Revenue FY 2011 · Dec 31, 2010 $0
Cash And Equivalents FY 2011 · Dec 31, 2009 $108.99K
Stockholders Equity FY 2011 · Dec 31, 2009 −$11.25M